MoonLake's CEO expresses confidence in 120mg being the optimal dose and highlights the drug's improved durability of response compared to Humira in other studies.
The long stock would be$Bruush Oral Care(BRSH.US)$. First its goal is to regain compliance over a 1.00. Second it has a new line of products to boost its next ER. Third the upside beats the downside. 500% in gains. The short stock would be$MoonLake Immunotherapeutics(MLTX.US)$It has just seen its highest run. Once it gets above 50.00 its loses investors interest.
BAO BMW :
master Mcsnacks, what happened to this $Bruush Oral Care (BRSH.US)$ ,it's when daily two week ago at 0.448, then suddenly all the way down from 0.38..0.33 .0.30. 0.28.0.26.0.25...now 0.2250...its this still good to holding?
Mcsnacks H Tupack楼主BAO BMW:
Borrow rate is at its highest. Short shares are at 0. And .22 is it's support. Bouncing off of it means this will run up to .39 again and try to break the resistance at .40.
$MoonLake Immunotherapeutics (MLTX.US)$ I have this skin condition, Hopefully they keep having good results with their medication. Hopefully this stock really flies again off this news.
MoonLake Immunotherapeutics股票讨论区
$Leap Therapeutics(LPTX.US)$ Phase 2
$Vera Therapeutics(VERA.US)$ Phase 2b
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$Akero Therapeutics(AKRO.US)$ Phase 2b
$Spruce Biosciences(SPRB.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$阿里拉姆制药(ALNY.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Annexon(ANNX.US)$ Phase 2a
$Roivant Sciences(ROIV.US)$...
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$阿里拉姆制药(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2...
The short stock would be $MoonLake Immunotherapeutics(MLTX.US)$ It has just seen its highest run. Once it gets above 50.00 its loses investors interest.
暂无评论